
PTSM: Pharmaceutical Technology Sourcing and Management
A recently released study by Accenture shows that sustainability is becoming an increasingly important part of the strategies and operations of companies.

PTSM: Pharmaceutical Technology Sourcing and Management
A recently released study by Accenture shows that sustainability is becoming an increasingly important part of the strategies and operations of companies.

Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.

Cases of overlooking proper packaging, reconstitution, directions, and dissolution.

Manufacturers and regulators on both sides of the ocean move to ensure the safety of heparin and other globally distributed drug products.

Industry can meet its responsibility to society by considering innovative pricing and partnerships.

Three therapies under review could help Americans attain a healthy weight.

Before embarking on an outsourcing relationship, it's important to be aware of FDA's expectations.

With more hands in the manufacturing pot, a good contingency plan is crucial to success.

Pharmaceutical Technology Europe
The FDA has approved the first generic version of the blockbuster low molecular weight heparin Lovenox (enoxaparin sodium), much to originator sanofi-aventis's displeasure.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Merck and Sinopharm Sign Agreement; Agilent Appoints CFO; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
French pharma giant Les Laboratoires Servier SA has been accused of providing "misleading" and "incorrect" information during the EC's antitrust investigation.

ePT--the Electronic Newsletter of Pharmaceutical Technology
In 2009, the European Commission (EC) Customs Union seized 11,462,533 medicines and medical products for suspected violations of intellectual property (IP), according to the Commission's annual report on EU Customs Enforcement of Intellectual Property Rights, which was published last week.

ePT--the Electronic Newsletter of Pharmaceutical Technology
A new report from the International Data Corporation (IDC) shows that life-science companies are increasingly using third-party outsourcing firms to augment or replace their information technology services.

ePT--the Electronic Newsletter of Pharmaceutical Technology
European Medicines Agency Issues Drug Review Update; And More

Pharmaceutical Technology Europe
Researchers claim that a dissolving microneedle patch may be able to offer improved vaccination against influenza compared with traditional needles, and also allow people without medical training to easily and safely administer the vaccine.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
ICH Draft Residual Solvents Guideline Published; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The Society of Chemical Manufacturers and Affiliates (SOCMA) expressed "strong concern" over legislation introduced in the US Senate earlier this month regarding chemical-site security.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Merck KGaA (Darmstadt, Germany), a global pharmaceutical and chemical company, completed its acquisition of Millipore (Billerica, MA), a life-science company, last Thursday for an aggregate purchase price of roughly EUR 5.2 billion ($6.7 billion).

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration has joined the Tox21 collaboration, which aims to develop ways to more effectively predict how chemicals will affect the body and environment.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Teva's and Sun Pharmaceuticals' motion to overturn a verdict issued against them in April 2010 for patent infringement has been denied by a US court, leaving the companies at the mercy of pharma giants Pfizer and Nycomed, who have said they will "vigorously" pursue damage claims.

Equipment and Processing Report
The pharmaceutical industry?s increasing interest in inhaled drugs has prompted several researchers to propose standard dissolution-testing methods for these products.

Equipment and Processing Report
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the July 2010 edition from Gems Sensors and Controls and Telstar.

Equipment and Processing Report
With the right technology tools, the sponsor organization and the contract manufacturer can have self-service, on-demand, and scheduled access to all manufacturing, quality, and process-development data.

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration announced last week that it will be "conducting a series of inspections in an effort to evaluate industry's compliance and understanding of [21 CFR] Part 11."

ePT--the Electronic Newsletter of Pharmaceutical Technology
Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology
States can reduce their Medicaid programs' healthcare expenditures by changing laws to enable generic drugs to be substituted for branded medications more easily and quickly, according to a new study conducted by CVS Caremark, a large pharmacy healthcare provider.

ePT--the Electronic Newsletter of Pharmaceutical Technology
McNeil Consumer Healthcare, a division of Johnson & Johnson (J&J), has once again expanded the recall of certain OTC products because of a musty or moldy odor, which has been linked to trace amounts of the chemical 2,4,6 triburomoanisole (TBA).

ePT--the Electronic Newsletter of Pharmaceutical Technology
The Laboratory Services Division of the Philippine Food and Drug Administration (FDA) has attained internationally recognized accreditation for its testing and calibration laboratories, according to a July 12, US Pharmacopeia (USP) announcement.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Merck & Co. (Whitehouse Station, NJ) released details of a restructuring plan last week, which calls for phasing out operations at eight research sites and eight manufacturing sites, resulting in a 15% reduction of its global workforce.